Search clinical trials for: ATORVASTATIN 80 mg

Total 11145 results

Organon and Co

Completed

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Hypercholesterolemia

China
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Organon and Co

Completed

Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

Hypercholesterolemia
Nearmedic Plus LLC
OCT LLC

Completed

Phase 1 Study of PBTZ169

Tuberculosis
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Esophageal Neoplasms

Japan
The Catholic University of Korea
Jeil Pharmaceutical Co., Ltd.

Terminated

The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) (PIONEER)

Coronary Artery Disease | Atherosclerosis

Korea, Republic of
Taipei Medical University Shuang Ho Hospital
University of Southern California

Enrolling by invitation

Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Chronic Kidney Diseases | Autosomal Dominant Polycystic Kidney Disease

Taiwan
Boehringer Ingelheim

Completed

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

Hypertension

France, Switzerland, Italy, Germany, Hong Kong, Netherlands, South Africa, Spain, Taiwan, Denmark, Sweden, Finland, Ireland, Korea, Republic of, Malaysia, Norway
Janssen Research & Development, LLC

Completed

A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

United States, Taiwan, Japan, Korea, Republic of, France, Mexico, Brazil, Sweden, Argentina, Ukraine, Canada, Spain, Germany, Poland, Belgium, Russian Federation, South Africa, Australia, Bulgaria
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

Hypercholesterolemia | LDL Cholesterol

United States
Seoul National University Hospital
JW Pharmaceutical

Unknown

Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

Metabolic Syndrome

Korea, Republic of
Abbott

Completed

Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

Rheumatoid Arthritis

China
Jeil Pharmaceutical Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Dyslipidemia With Hypertension

Korea, Republic of
EMS

Completed

Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia

Dyspepsia

Brazil
University of California, San Diego

Recruiting

Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2 (PNLABXPART2)

Sepsis | Nephrolithiasis | Urinary Tract Infection (UTI)

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

Healthy

United States
AstraZeneca

Completed

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Type 2 Diabetes | Albuminuria | Hyperuricemia

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID); Pfizer

Completed

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

HIV-1 Infection

United States, Puerto Rico
Chiang Mai University

Completed

Effect of Simethicone on Reducing Bowel Interference During Tubal Resection

Sterility, Postpartum

Thailand
Eli Lilly and Company

Completed

A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-1)

Psoriasis

Italy, United States, Australia, Germany, Canada, Denmark, Japan, Poland, Hungary, Romania, United Kingdom
Shiraz University of Medical Sciences

Completed

Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting

Coronary Stenting

Iran, Islamic Republic of
Virgilio Paolo Carnielli

Not yet recruiting

Medium vs Low Oxygen Threshold for the Surfactant Administration

Respiratory Distress Syndrome
Dr. Reddy's Laboratories Limited

Completed

Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases (Omez-RU2013)

GERD
Optimer Pharmaceuticals LLC

Completed

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

Healthy

United States
Moberg Pharma AB

Completed

Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Germany, United Kingdom, Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT (CARAMEL)

Diabetes Mellitus, Type 2 | Vascular Inflammation

Netherlands
NRG Oncology
National Cancer Institute (NCI)

Completed

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Metastatic Endometrioid Adenocarcinoma

United States
Organon and Co
PT. Schering-Plough. Tbk Indonesia

Completed

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Hypercholesterolemia | Coronary Arteriosclerosis
AstraZeneca

Completed

Phase I, Study in Chinese NSCLC Patients (AURAChinaPK)

Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive

China
First Affiliated Hospital Xi'an Jiaotong University

Unknown

How Atorvastatin Affects the Gut Flora and Metabolomics?

Atherosclerotic Cardiovascular Disease

China
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Lipitor Tablets (ALWAYS)

Hypercholesterolemia

Japan
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First Line Osimertinib in the Real World: an Inter-regional Prospective Study (FLOWER)

EGF-R Positive Non-Small Cell Lung Cancer

Italy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Migraine With or Without Aura
The Leeds Teaching Hospitals NHS Trust

Completed

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Arrhythmogenic Right Ventricular Cardiomyopathy
Minia University

Recruiting

Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index

Renal Protection

Egypt
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Hadassah Medical Organization

Terminated

Optimal Analgesia in Acute Gastroenteritis

Gastroenteritis

Israel
AstraZeneca

Recruiting

A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) (TARGET)

Stage II-IIIB Non-small Cell Lung Carcinoma

Spain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using Atorvastatin (Sortis)

Proteinuria | Chronic Kidney Disease
Tanta University

Not yet recruiting

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

Breast Cancer Female
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Hypercholesterolemia, Dyslipidemia

Korea, Republic of
Aptissen SA
Noblewell

Completed

An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Osteoarthritis, Knee

Poland
Peking Union Medical College Hospital

Recruiting

Survival Benefits of Statins in Breast Cancer Patients (SBSBC)

Breast Cancer Female

China
Ain Shams University

Recruiting

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Doxorubicin Induced Cardiomyopathy

Egypt
Brigham and Women's Hospital

Not yet recruiting

Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

OSA

United States
Novartis Pharmaceuticals

Completed

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

Hypertension

China
University of Florida

Completed

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Completed

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Diabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, Nonalcoholic

United States, Canada
Samsung Medical Center

Withdrawn

Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)

Lung Cancer

Korea, Republic of

Search clinical trials for: ATORVASTATIN 80 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations